abstract |
The present invention relates to an antibody molecule having specificity for an antigenic determinant of IL-17, a therapeutic use of the antibody molecule, and a method for producing said antibody molecule. Provided are antibody molecules having specificity for a group, therapeutic uses of antibody molecules, and methods for generating said antibody molecules. [Selection figure] None |